Two Vaccine Targets on Virus May Be Better Than One

An experimental vaccine developed by GeoVax Labs succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study.
Reuters Health Information

source https://www.medscape.com/viewarticle/970179?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?